Microneedle Array‐Based Dermal Interstitial Fluid Biopsy for Cancer Diagnosis: Advances and Challenges
Advanced Healthcare Materials · 2025-03 · 14 (7)
DOI: 10.1002/adhm.202404420 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 29.01.2025. Verfasst von Chaima Merzougui und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science & Medical Engineering, Southeast University, Nanjing, 211189, China. Hauptthemen laut MEDLINE: Extracellular Fluid, Neoplasms, Needles, Skin. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 128 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shenzhen Science and Technology Plan Project, National Natural Science Foundation of China, Jiangsu Provincial Key Research and Development Program.
Abstract (Originalsprache)
Current early cancer diagnostic technologies, such as imaging, molecular tests, endoscopic techniques, and biopsies, face considerable challenges in low‐and middle‐income countries (LMICs) due to high costs, procedural complexity, and limited resource access. Microneedle‐based liquid biopsy for skin interstitial fluid (ISF) offers a practical and minimally invasive alternative for cancer diagnosis in these settings. This review systematically examines ISF liquid biopsy methods for their effectiveness in capturing cancer biomarkers directly from the skin and assesses their potential to address diagnostic needs in low‐resource environments. Recent innovations in microneedle design and ISF underscore their potential in enabling early, accessible cancer detection tailored to LMICs' needs. Additionally, integrating artificial intelligence (AI) for data interpretation is proposed as a way to enhance diagnostic accuracy and enable real‐time point‐of‐care (POC) applications. Collectively, these advances illustrate a flexible, scalable model for accessible cancer diagnostics, with significant implications for improving early detection and healthcare quality in resource‐limited environments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, School of Biological Science & Medical Engineering, Southeast University, Nanjing, 211189, China.
- Southeast University Shenzhen Research Institute, Shenzhen, 518000, China.
- Institute of Biomaterials and Medical Devices, Southeast University, Suzhou, 215163, China.
- Rehabilitation Medical Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, 210029, China.
ORCID-Profile: Xiangwei Zhao
Förderung
- National Natural Science Foundation of China
- Shenzhen Science and Technology Plan Project
- National Natural Science Foundation of China, Jiangsu Provincial Key Research and Development Program
- Jiangsu Provincial Key Research and Development Program
Zitieren
APA
Merzougui, C., Yang, X., Meng, D., Huang, Y., & Zhao, X. (2025). Microneedle Array‐Based Dermal Interstitial Fluid Biopsy for Cancer Diagnosis: Advances and Challenges. Advanced Healthcare Materials, 14(7). https://doi.org/10.1002/adhm.202404420
Vancouver
Merzougui C, Yang X, Meng D, Huang Y, Zhao X. Microneedle Array‐Based Dermal Interstitial Fluid Biopsy for Cancer Diagnosis: Advances and Challenges. Advanced Healthcare Materials. 2025;14(7). doi:10.1002/adhm.202404420
BibTeX
@article{Merzougui2025,
author = {Merzougui, Chaima and Yang, Xi and Meng, Dianhuai and Huang, Yan and Zhao, Xiangwei},
title = {Microneedle Array‐Based Dermal Interstitial Fluid Biopsy for Cancer Diagnosis: Advances and Challenges},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {7},
doi = {10.1002/adhm.202404420}
}
EUVIMED